Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Cambodian Prime Minister Joins Push to Boycott Drug Trials

August 3, 2004

On Tuesday, Prime Minister Hun Sen denounced plans for a human HIV drug trial in impoverished Cambodia, which was chosen because of its high HIV infection rate of about 2.6 percent. While not mentioning the trial by name, Hun Sen appeared to be referring to the controversial study to test the antiretroviral drug tenofovir DF on nearly 1,000 Cambodian sex workers. The Bill and Melinda Gates Foundation is funding the study -- a joint effort between Cambodia's health ministry, Australia's University of New South Wales and the University of California-San Francisco.

"Please don't use Cambodian human beings to test the HIV vaccine. Please test it on the animals," said Hun Sen at a children's hospital ceremony in the capital attended by more than 1,000 health care workers, diplomats and politicians.

Though several large nongovernmental organizations back the study, it has been summarily rejected by Cambodia's Women's Network for Unity (WNU), a sex workers' union. WNU cited the study's failure to offer long-term medical care or a 30-year guarantee against side effects. The 150-member group also believes poorly educated women might obtain a false sense of security because of the study, causing them to engage in unprotected sex.

Advertisement
The study's goal is to determine whether tenofovir DF is effective in preventing new HIV infections in healthy, sexually active adults.

WNU liaison officer Sou Sotheavy applauded Hun's comments. "We are very glad Hun Sen has chosen to support us in this," said Sou.

Back to other news for August 3, 2004

Adapted from:
Deutsche Presse-Agentur
08.03.04

  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
 

 

Advertisement